- Silexion Therapeutics press release (NASDAQ:SLXN): Q1 GAAP EPS of $0.26.
- Cash and cash equivalents were $6.2 million as of March 31, 2025, compared to $1.2 million as of December 31, 2024.
Silexion Therapeutics GAAP EPS of $0.26
.png)
1 month ago
3
Related
Dr. Reddy’s Laboratories shares to go ex-dividend tomorrow. ...
56 minutes ago
0
Asian stocks cautious as tariff talk sinks copper
2 hours ago
1
Popular
UK's unemployment rate rises to 4.6% in April
4 weeks ago
32
English (US) · © Insaro Search Engines 2025. All rights are reserved